R Pg Family Wealth Advisory, LLC Mersana Therapeutics, Inc. Transaction History

R Pg Family Wealth Advisory, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$13.28 - $18.07 $12,616 - $17,166	-950 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$16.84 - $27.59 $15,223 - $24,941	-904 Reduced 48.76%	950 $25,000
Q2 2020 Aug 10, 2020	SELL	$5.24 - $23.4 $4,092 - $18,275	-781 Reduced 29.64%	1,854 $43,000
Q1 2020 May 14, 2020	BUY	$4.41 - $9.28 $11,620 - $24,452	2,635 New	2,635 $15,000

121

116M

233K

457K

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $194M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

Get notified when there are updates to the investment portfolio of R Pg Family Wealth Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on R Pg Family Wealth Advisory, LLC with notifications on news.